Literature DB >> 10619492

The kinetic origins of the restriction point in the mammalian cell cycle.

B D Aguda1, Y Tang.   

Abstract

A detailed model mechanism for the G1/S transition in the mammalian cell cycle is presented and analysed by computer simulation to investigate whether the kinetic origins of the restriction point (R-point) can be identified. The R-point occurs in mid-to-late G1 phase and marks the transition between mitogen-dependent to mitogen-independent progression of the cell cycle. For purposes of computer simulations, the R-point is defined as the first point in time after mitosis where cutting off mitogen stimulation does not prevent the cell reaching the threshold activity of cyclin-E/cdk2 required for entry into S phase. The key components of the network that generate a dynamic switching behaviour associated with the R-point include a positive feedback loop between cyclin-E/cdk2 and Cdc25A, along with the mutually negative interaction between the cdk inhibitor p27Kip1 and cyclin-E/cdk2. Simulations of the passage through the R-point were carried out and the factors affecting the position of the R-point in G1 are determined. The detailed model also shows various points in the network where the activation of cyclin-E/cdk2 can be initiated with or without the involvement of the retinoblastoma protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619492      PMCID: PMC6726334          DOI: 10.1046/j.1365-2184.1999.3250321.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  43 in total

1.  Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.

Authors:  K Alevizopoulos; J Vlach; S Hennecke; B Amati
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

Review 2.  E2F: a nodal point in cell cycle regulation.

Authors:  R Bernards
Journal:  Biochim Biophys Acta       Date:  1997-12-09

Review 3.  The retinoblastoma protein pathway in cell cycle control and cancer.

Authors:  J Bartek; J Bartkova; J Lukas
Journal:  Exp Cell Res       Date:  1997-11-25       Impact factor: 3.905

4.  Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein.

Authors:  M R Campanero; E K Flemington
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

5.  Cyclin E-CDK2 is a regulator of p27Kip1.

Authors:  R J Sheaff; M Groudine; M Gordon; J M Roberts; B E Clurman
Journal:  Genes Dev       Date:  1997-06-01       Impact factor: 11.361

6.  Regulation of the cyclin E gene by transcription factor E2F1.

Authors:  K Ohtani; J DeGregori; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

7.  Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase.

Authors:  W Krek; M E Ewen; S Shirodkar; Z Arany; W G Kaelin; D M Livingston
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

8.  Instabilities in phosphorylation-dephosphorylation cascades and cell cycle checkpoints.

Authors:  B D Aguda
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

9.  Cdc25 cell-cycle phosphatase as a target of c-myc.

Authors:  K Galaktionov; X Chen; D Beach
Journal:  Nature       Date:  1996-08-08       Impact factor: 49.962

10.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

Authors:  A Koff; A Giordano; D Desai; K Yamashita; J W Harper; S Elledge; T Nishimoto; D O Morgan; B R Franza; J M Roberts
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

View more
  30 in total

1.  Dynamics of the cell cycle: checkpoints, sizers, and timers.

Authors:  Zhilin Qu; W Robb MacLellan; James N Weiss
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

2.  Multisite phosphorylation and network dynamics of cyclin-dependent kinase signaling in the eukaryotic cell cycle.

Authors:  Ling Yang; W Robb MacLellan; Zhangang Han; James N Weiss; Zhilin Qu
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

3.  Analysis of a generic model of eukaryotic cell-cycle regulation.

Authors:  Attila Csikász-Nagy; Dorjsuren Battogtokh; Katherine C Chen; Béla Novák; John J Tyson
Journal:  Biophys J       Date:  2006-03-31       Impact factor: 4.033

Review 4.  The role of modelling in identifying drug targets for diseases of the cell cycle.

Authors:  Robert G Clyde; James L Bown; Ted R Hupp; Nikolai Zhelev; John W Crawford
Journal:  J R Soc Interface       Date:  2006-10-22       Impact factor: 4.118

5.  Biological switches and clocks.

Authors:  John J Tyson; Reka Albert; Albert Goldbeter; Peter Ruoff; Jill Sible
Journal:  J R Soc Interface       Date:  2008-08-06       Impact factor: 4.118

6.  Temporal self-organization of the cyclin/Cdk network driving the mammalian cell cycle.

Authors:  Claude Gérard; Albert Goldbeter
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

Review 7.  The role of Cdc25A in the regulation of cell proliferation and apoptosis.

Authors:  Tao Shen; Shile Huang
Journal:  Anticancer Agents Med Chem       Date:  2012-07       Impact factor: 2.505

8.  Bistability, oscillations, and traveling waves in frog egg extracts.

Authors:  John J Tyson; Bela Novak
Journal:  Bull Math Biol       Date:  2014-09-04       Impact factor: 1.758

9.  Sophisticated framework between cell cycle arrest and apoptosis induction based on p53 dynamics.

Authors:  Hiroyuki Hamada; Yoshihiko Tashima; Yu Kisaka; Kazunari Iwamoto; Taizo Hanai; Yukihiro Eguchi; Masahiro Okamoto
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

10.  Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation.

Authors:  Roberta Alfieri; Matteo Barberis; Ferdinando Chiaradonna; Daniela Gaglio; Luciano Milanesi; Marco Vanoni; Edda Klipp; Lilia Alberghina
Journal:  BMC Bioinformatics       Date:  2009-10-15       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.